Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-91.99	7.62	-95.19
Graham Fair Price	1007.44	0.25	0.02
PEG	-99.22	< 0.005	-0.02
Price/Book	-85.63	0.53	3.67
Price/Cash Flow	92.82	-18.57	-258.52
Prices/Earnings	-92.82	0.23	3.17
Price/Sales	-92.82	0.37	5.21
Price/FCF	92.82	-18.57	-258.52
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.01	0.01
Operating Margin	-21.04	-0.05	-0.04
ROA	100.00	0.56	0.28
ROE	0.29	0.58	100.00
ROIC	-0.03	-0.07	-140.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	12.41	-0.98	1170.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.73	-17.96	2344.44
EPS QOQ	1.61	14.80	819.39
FCF QOQ	1.00	-14.66	1371.11
Revenue QOQ	2.53	14.66	479.22
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-0.02	-100.00
Days Sales Outstanding (DSO)	0.00	0.95	100.00
Inventory Turnover	0.00	-3786.31	-100.00
Debt/Capitalization	< 0.005	0.01	70.46
Quick Ratio	24.33	24.43	0.43
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	< 0.005	0.07	683.08
Cash	< 0.005	0.07	675.05
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	-1466.16
Revenue	< 0.005	0.10	1466.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	24.39	24.39	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	35.96	16.09	-55.24
Naive Interpretation	Member

06 - Financial Health · Bad

Rating